Literature DB >> 14695736

Mobilization of opioid-containing polymorphonuclear cells by hematopoietic growth factors and influence on inflammatory pain.

Alexander Brack1, Heike L Rittner, Halina Machelska, Karin Beschmann, Nicolle Sitte, Michael Schäfer, Christoph Stein.   

Abstract

BACKGROUND: Leukocytes can control inflammatory pain by secretion of opioid peptides, stimulated by cold-water swimming or local injection of corticotropin-releasing factor, and subsequent activation of opioid receptors on peripheral sensory neurons. This study investigated whether mobilization of polymorphonuclear cells (PMN) by granulocyte colony-stimulating factor (G-CSF) and stem cell factor (SCF) enhances immigration of opioid-containing PMN and peripheral opioid analgesia in rats with Freund complete adjuvant-induced hind paw inflammation.
METHODS: In circulating PMN of rats treated with G-CSF+SCF and sham-treated rats, opioid peptide content was measured by radioimmunoassay. Expression of adhesion molecules (CD62L, CD49d, CD18), in vitro migration in the Boyden chamber, and infiltrating leukocytes were analyzed by flow cytometry. Chemokine messenger RNA transcription was quantified by LightCycler polymerase chain reaction. Paw pressure threshold was measured at baseline, after cold-water swimming, and after injection of corticotropin-releasing factor.
RESULTS: G-CSF+SCF treatment increased circulating PMN (11-fold, P < 0.05). Mobilized PMN had decreased content of beta-endorphin but not of Met-enkephalin per cell, down-regulation of CD62L, up-regulation of CD49d (but no change in CD18), and reduced migration toward higher chemokine concentrations (all P < 0.05). In the paw, one of four chemokine messenger RNAs was significantly expressed during the first 2 h of inflammation (P < 0.05), immigration of PMN and opioid-containing cells was slightly increased (1.5-fold, P < 0.05), and baseline paw pressure threshold, as well as paw pressure threshold increases induced by corticotropin-releasing factor and cold-water swimming, were unchanged (P > 0.05).
CONCLUSIONS: G-CSF+SCF mobilized circulating opioid-containing PMN but had a minor influence on cell migration and peripheral analgesia, probably because of the low expression of chemokines in the inflamed paw and one of the decreased beta-endorphin content in PMN.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14695736     DOI: 10.1097/00000542-200401000-00024

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  19 in total

Review 1.  Peripheral mechanisms of pain and analgesia.

Authors:  Christoph Stein; J David Clark; Uhtaek Oh; Michael R Vasko; George L Wilcox; Aaron C Overland; Todd W Vanderah; Robert H Spencer
Journal:  Brain Res Rev       Date:  2008-12-31

Review 2.  Opioids and the immune system - friend or foe.

Authors:  Lisanne Mirja Plein; Heike L Rittner
Journal:  Br J Pharmacol       Date:  2017-03-23       Impact factor: 8.739

3.  Transient opening of the perineurial barrier for analgesic drug delivery.

Authors:  Dagmar Hackel; Susanne M Krug; Reine-Solange Sauer; Shaaban A Mousa; Alexander Böcker; Diana Pflücke; Esther-Johanna Wrede; Katrin Kistner; Tali Hoffmann; Benedikt Niedermirtl; Claudia Sommer; Laura Bloch; Otmar Huber; Ingolf E Blasig; Salah Amasheh; Peter W Reeh; Michael Fromm; Alexander Brack; Heike L Rittner
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-25       Impact factor: 11.205

4.  Rapid heterologous desensitization of antinociceptive activity between mu or delta opioid receptors and chemokine receptors in rats.

Authors:  Xiaohong Chen; Ellen B Geller; Thomas J Rogers; Martin W Adler
Journal:  Drug Alcohol Depend       Date:  2006-10-17       Impact factor: 4.492

5.  Evaluation of the peripheral analgesic effect of sufentanil lipid nanoparticles.

Authors:  Hongjun Li; Hui Qiao; Hongjie Lu; Changqi Liu
Journal:  J Anesth       Date:  2014-03-07       Impact factor: 2.078

6.  Early systemic granulocyte-colony stimulating factor treatment attenuates neuropathic pain after peripheral nerve injury.

Authors:  Po-Kuan Chao; Kwok-Tung Lu; Yun-Lin Lee; Jin-Chung Chen; Hung-Li Wang; Yi-Ling Yang; Mei-Yun Cheng; Ming-Feng Liao; Long-Sun Ro
Journal:  PLoS One       Date:  2012-08-24       Impact factor: 3.240

7.  The connection of monocytes and reactive oxygen species in pain.

Authors:  Dagmar Hackel; Diana Pflücke; Annick Neumann; Johannes Viebahn; Shaaban Mousa; Erhard Wischmeyer; Norbert Roewer; Alexander Brack; Heike Lydia Rittner
Journal:  PLoS One       Date:  2013-05-02       Impact factor: 3.240

Review 8.  Leukocytes as mediators of pain and analgesia.

Authors:  Heike L Rittner; Alexander Brack
Journal:  Curr Rheumatol Rep       Date:  2007-12       Impact factor: 4.686

Review 9.  Leukocyte-derived opioid peptides and inhibition of pain.

Authors:  Halina Machelska; Christoph Stein
Journal:  J Neuroimmune Pharmacol       Date:  2006-03       Impact factor: 7.285

10.  Mycobacteria attenuate nociceptive responses by formyl peptide receptor triggered opioid peptide release from neutrophils.

Authors:  Heike L Rittner; Dagmar Hackel; Philipp Voigt; Shaaban Mousa; Andrea Stolz; Dominika Labuz; Michael Schäfer; Michael Schaefer; Christoph Stein; Alexander Brack
Journal:  PLoS Pathog       Date:  2009-04-03       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.